3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
77
Squamous Cell Carcinoma of Head and Neck
42
Lung Neoplasms
36
Urinary Bladder Neoplasms
22
Oropharyngeal Neoplasms
21
Nasopharyngeal Carcinoma
19
Head and Neck Neoplasms
18
Biliary Tract Neoplasms
16
Carcinoma
15
Small Cell Lung Carcinoma
14
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Esophageal Squamous Cell Carcinoma
14
Cholangiocarcinoma
14
Neoplasm Metastasis
13
Uterine Cervical Neoplasms
12
Ovarian Neoplasms
12
Neoplasms
12
Colorectal Neoplasms
12
Pancreatic Neoplasms
11
Laryngeal Neoplasms
10
Carcinoma, Squamous Cell
10
Stomach Neoplasms
9
Gallbladder Neoplasms
9
Mouth Neoplasms
8
Endometrial Neoplasms
8
Carcinoma, Transitional Cell
8
Hypopharyngeal Neoplasms
7
Esophageal Neoplasms
7
Bile Duct Neoplasms
7
Triple Negative Breast Neoplasms
6
Interventions
Bevacizumab
3
contrast agent BR1
2
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Microbubbles
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
Biopsy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Nerve Tissue
×
Cisplatin
×
90 days
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts